查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1757439

妊娠纹治疗市场：全球产业分析、市场规模、份额、成长、趋势与未来预测（2025-2032）

Stretch Marks Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 201 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research 最近发布了一份关于全球妊娠纹治疗市场的综合报告。该报告全面评估了市场驱动因素、趋势、机会、驱动因素和挑战等关键市场动态，并深入分析了市场结构。研究报告提供了独家数据和统计数据，概述了 2025 年至 2032 年全球妊娠纹治疗市场的预测成长轨迹。

关键见解

  • 妊娠纹治疗市场规模（2025年）：29.234亿美元
  • 市场规模预测（以金额为准，2032 年）：43.38 亿美元
  • 全球市场成长率（2025-2032年复合年增长率）：5.8%

妊娠纹治疗市场：分析范围

妊娠纹治疗包括多种解决方案，旨在减少或消除妊娠纹（膨胀纹），这些纹路是由怀孕、体重波动、荷尔蒙变化等引起的。疗程多样，从局部涂抹乳霜和精油，到雷射治疗、微晶换肤和化学换肤，不一而足。妊娠纹治疗市场面向皮肤科诊所、美容中心、药局和家庭消费者。人们日益增强的美容意识、非侵入性治疗技术的进步以及对个人化护肤解决方案日益增长的需求，是妊娠纹治疗发展的驱动力。

市场成长动力：

全球妊娠纹治疗市场受多种关键因素驱动，例如对美容手术的需求不断增长，尤其是在20至40岁女性群体中。人们对皮肤健康的认识不断提高，以及飞梭雷射和射频等微创治疗手段的普及，正在推动市场对妊娠纹的接受度。此外，天然和有机护肤配方的日益普及，也推动了植物来源和草药疗法在妊娠纹护理领域的兴起。社群媒体影响力人士、明星代言以及日益壮大的电商平台也显着提升了消费者参与度和市场渗透率。

市场限制：

儘管妊娠纹治疗市场成长潜力巨大，但也面临许多限制因素，例如疗效参差不齐以及产品类型缺乏标准化。雷射和微针等先进治疗方法价格昂贵，限制了其普及性，尤其是在价格敏感的市场。此外，新化妆品配方核准的监管复杂性以及化学疗法的潜在副作用可能会阻碍市场扩张。消费者对产品功效的质疑以及见效时间的长短，也对推广应用构成了进一步的挑战。

市场机会：

妊娠纹治疗市场蕴含着巨大的商机，这得益于护肤配方的创新、皮肤科服务的拓展以及男性对美容护理日益增长的兴趣。亚太和拉丁美洲新兴市场的消费者在美容和个人护理方面的支出正在增长，这为市场提供了新的成长途径。集抗衰老、保湿和改善妊娠纹功效于一体的多功能产品的开发，可望刺激产品需求。此外，远距皮肤科和线上护肤咨询将扩大消费者机会专家指导的管道，从而改善治疗效果并提升市场参与。化妆品品牌、皮肤科医生和生技公司之间的合作有望催生新的治疗方法，并开拓新的细分市场。

本报告回答的关键问题

  • 推动全球妊娠纹治疗市场成长的关键因素有哪些？
  • 哪些治疗类型和交付管道在各个消费者群体中越来越受欢迎？
  • 技术进步和天然成分趋势如何影响产品创新？
  • 哪些主要企业正在为妊娠纹治疗市场做出贡献，他们采取了哪些策略来维持市场相关性？
  • 全球妊娠纹治疗市场有哪些新兴趋势与前景？

目录

第一章执行摘要

第二章 市场概述

  • 市场范围和定义
  • 价值链分析
  • 宏观经济因素
    • 世界GDP展望
    • 世界GDP展望
    • 全球经济成长预测
    • 全球都市化进程
    • 其他宏观经济因素
  • 预测因子：相关性和影响力
  • COVID-19影响评估
  • PESTLE分析
  • 波特五力分析
  • 地缘政治紧张局势：市场影响
  • 监管和技术格局

第三章 市场动态

  • 驱动程式
  • 限制因素
  • 机会
  • 趋势

第四章 价格趋势分析（2019-2032）

  • 区域定价分析
  • 按细分市场定价
  • 影响价格的因素

第五章。全球妊娠纹治疗市场展望：过去（2019-2024 年）与预测（2025-2032 年）

  • 主要亮点
  • 全球妊娠纹治疗市场（按治疗方法）展望
    • 简介/主要发现
    • 治疗方法的历史市场规模表现（价值（百万美元），2019-2024 年）
    • 目前市场规模预测（按治疗方法划分）（价值（百万美元），2025-2032 年）
      • 外用药物
        • 凝胶
        • 奶油
        • 油/精华液
      • 程序性治疗
        • 射频治疗
        • 非剥脱性点阵表面置换
        • 烧蚀雷射表面置换
        • 红外线设备/辐射
        • 皮肤脱皮
        • 化学换肤
    • 市场吸引力分析：按治疗方法
  • 全球妊娠纹治疗市场展望（依妊娠纹类型划分）
    • 简介/主要发现
    • 妊娠纹类型历史市场规模表现（价值（百万美元），2019-2024 年）
    • 目前市场规模预测（按妊娠纹类型划分）（价值（百万美元），2025-2032 年）
      • 萎缩性条纹（皮变薄）
      • 妊娠纹（产后）
      • 皮肤拉伸（皮肤拉伸）
      • 深红色条纹（红色）
      • 条纹（白色）
      • 黑条纹（黑色）
      • 青色条纹（深蓝色）
    • 依妊娠纹类型进行市场吸引力分析
  • 全球妊娠纹治疗市场前景（依最终用户）
    • 简介/主要发现
    • 按最终用户分類的历史市场规模表现（价值（百万美元），2019-2024 年）
    • 目前市场规模预测（按最终用户划分）（价值（百万美元），2025-2032 年）
      • 医院
      • 皮肤科诊所
      • 美容诊所
      • 健康水疗中心
      • 居家医疗
    • 最终用户的市场吸引力分析

第六章全球妊娠纹治疗市场按地区展望

  • 主要亮点
  • 按地区分類的历史市场规模分析（价值（百万美元），2019-2024 年）
  • 各地区目前市场规模预测（价值（百万美元），2025-2032 年）
    • 北美洲
    • 欧洲
    • 东亚
    • 南亚和大洋洲
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：按地区

第七章北美妊娠纹治疗市场展望：历史（2019-2024 年）与预测（2025-2032 年）

第 8 章欧洲妊娠纹治疗市场展望：历史（2019-2024 年）与预测（2025-2032 年）

第九章东亚妊娠纹治疗市场展望：历史（2019-2024）与预测（2025-2032）

第 10 章南亚和大洋洲妊娠纹治疗市场展望：历史（2019-2024 年）和预测（2025-2032 年）

第 11 章拉丁美洲妊娠纹治疗市场展望：历史（2019-2024 年）与预测（2025-2032 年）

第 12 章中东和非洲妊娠纹治疗市场展望：历史（2019-2024 年）和预测（2025-2032 年）

第十三章竞争格局

  • 市场占有率分析（2025年）
  • 市场结构
    • 竞争强度图：按市场
    • 竞争仪錶板
  • 公司简介
    • Weleda
    • Clarins
    • basq NYC
    • Body Merry
    • Himalaya Global Holdings Ltd.
    • Stratpharma AG（Stratpharma Inc.）
    • Browne Drug Co., Inc.（Palmer's）
    • Mederma（HRA Pharma）
    • Givaudan SA
    • NEOSTRATA COMPANY, INC.（Johnson &Johnson Services, Inc.）
    • Bio-Oil（Union Swiss（Pty）Ltd）
    • Merz Pharma
    • Dermaclara
    • Unilever

第十四章 附录

  • 调查方法
  • 调查前提
  • 首字母缩写和简称
简介目录
Product Code: PMRREP33375

Persistence Market Research has recently released a comprehensive report on the worldwide market for stretch marks treatment. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global stretch marks treatment market from 2025 to 2032.

Key Insights:

  • Stretch Marks Treatment Market Size (2025E): USD 2,923.4 Million
  • Projected Market Value (2032F): USD 4,338.0 Million
  • Global Market Growth Rate (CAGR 2025 to 2032): 5.8%

Stretch Marks Treatment Market - Report Scope:

Stretch marks treatment includes a variety of solutions aimed at minimizing or eliminating the appearance of striae distensae (stretch marks), commonly resulting from pregnancy, weight fluctuations, or hormonal changes. Treatment methods range from topical creams and oils to laser therapy, microdermabrasion, and chemical peels. The stretch marks treatment market caters to dermatology clinics, beauty centers, pharmacies, and at-home consumers. Growth is driven by increasing aesthetic awareness, advancements in non-invasive treatment technologies, and growing demand for personalized skincare solutions.

Market Growth Drivers:

The global stretch marks treatment market is propelled by several key factors, including the rising demand for aesthetic procedures, particularly among women aged 20-40. Increased awareness of dermatological health and the availability of minimally invasive treatments such as fractional lasers and radiofrequency therapy are accelerating market adoption. Furthermore, the growing popularity of natural and organic skincare formulations supports the rise of plant-based and herbal remedies in stretch marks care. Social media influence, celebrity endorsements, and expanding e-commerce platforms are also major contributors to consumer engagement and market penetration.

Market Restraints:

Despite strong growth potential, the stretch marks treatment market faces notable restraints, such as inconsistent treatment efficacy and lack of standardization across product categories. The high cost of advanced treatment modalities like laser and microneedling therapy limits accessibility, particularly in price-sensitive markets. Additionally, regulatory complexities concerning the approval of new cosmetic formulations and potential side effects of chemical-based treatments can hinder market expansion. Consumer skepticism regarding product claims and the long duration required to see visible results further challenge widespread adoption.

Market Opportunities:

The stretch marks treatment market presents substantial opportunities driven by innovation in skincare formulations, expansion of dermatological services, and growing male interest in aesthetic treatments. Emerging markets in Asia Pacific and Latin America show increasing consumer spending on beauty and personal care, offering new growth avenues. The development of multifunctional products combining anti-aging, moisturizing, and stretch mark-reducing properties can boost product demand. In addition, teledermatology and online skincare consultations expand consumer access to expert guidance, improving treatment outcomes and market outreach. Collaborations between cosmetic brands, dermatologists, and biotech firms are likely to foster novel treatment approaches and unlock new market segments.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the stretch marks treatment market globally?
  • Which treatment types and delivery channels are gaining popularity among different consumer demographics?
  • How are technological advancements and natural ingredient trends shaping product innovation?
  • Who are the key players contributing to the stretch marks treatment market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global stretch marks treatment market?

Competitive Intelligence and Business Strategy:

These companies invest in R&D to develop clinically tested formulations enriched with ingredients like retinol, centella asiatica, and hyaluronic acid. Partnerships with dermatologists and beauty influencers, along with omnichannel distribution strategies, enhance consumer engagement. Emphasis on clean beauty, sustainability, and customized skincare solutions further drives competitive differentiation and consumer loyalty.

Key Companies Profiled:

  • Weleda
  • Clarins
  • basq NYC
  • Body Merry
  • Himalaya Global Holdings Ltd.
  • Stratpharma AG (Stratpharma Inc.)
  • Browne Drug Co., Inc. (Palmer's)
  • Mederma (HRA Pharma)
  • Givaudan SA
  • NEOSTRATA COMPANY, INC. (Johnson & Johnson Services, Inc.)
  • Bio-Oil (Union Swiss (Pty) Ltd)
  • Merz Pharma
  • Dermaclara
  • Unilever

Stretch Marks Treatment Market Research Segmentation:

The stretch marks treatment market encompasses a diverse range of products, technologies, applications, and consumer segments, addressing varying degrees of skin damage and consumer preferences.

By Treatment:

Topical Medications

*Gels

*Creams

*Oils/Serums

Procedural Treatments

*Radiofrequency Therapy

*Non-ablative Laser Fractional Resurfacing

*Ablative Laser Resurfacing

*Infrared Devices/Radiations

*Dermabrasion

*Chemical Peels

By Stretch Mark Type:

  • Striae atrophicans (Thinned Skin)
  • Striae gravidarum (Post Pregnancy)
  • Striae distensae (Stretched Skin)
  • striae rubrae (Red)
  • Striae albae (White)
  • Striae nigra (Black)
  • Striae caerulea (Dark Blue)

By End User:

  • Hospitals
  • Dermatology Clinics
  • Aesthetic Clinics
  • Wellness and Spa Centers
  • Home Care Settings

By Region:

  • North America
  • Latin America
  • Europe Stretch
  • South Asia Stretch
  • East Asia Stretch
  • Oceania Stretch
  • The Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Stretch Marks Treatment Market Snapshot 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Industry Developments and Key Market Events
  • 1.5. Demand Side and Supply Side Analysis
  • 1.6. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definitions
  • 2.2. Value Chain Analysis
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global GDP Outlook
    • 2.3.2. Global GDP Outlook
    • 2.3.3. Global economic Growth Forecast
    • 2.3.4. Global Urbanization Growth
    • 2.3.5. Other Macro-economic Factors
  • 2.4. Forecast Factors - Relevance and Impact
  • 2.5. COVID-19 Impact Assessment
  • 2.6. PESTLE Analysis
  • 2.7. Porter's Five Forces Analysis
  • 2.8. Geopolitical Tensions: Market Impact
  • 2.9. Regulatory and Technology Landscape

3. Market Dynamics

  • 3.1. Drivers
  • 3.2. Restraints
  • 3.3. Opportunities
  • 3.4. Trends

4. Price Trend Analysis, 2019-2032

  • 4.1. Region-wise Price Analysis
  • 4.2. Price by Segments
  • 4.3. Price Impact Factors

5. Global Stretch Marks Treatment Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 5.1. Key Highlights
  • 5.2. Global Stretch Marks Treatment Market Outlook: Treatment
    • 5.2.1. Introduction/Key Findings
    • 5.2.2. Historical Market Size (US$ Mn) Analysis by Treatment, 2019-2024
    • 5.2.3. Current Market Size (US$ Mn) Forecast, by Treatment, 2025-2032
      • 5.2.3.1. Topical Medications
        • 5.2.3.1.1. Gels
        • 5.2.3.1.2. Creams
        • 5.2.3.1.3. Oils/Serums
      • 5.2.3.2. Procedural Treatments
        • 5.2.3.2.1. Radiofrequency Therapy
        • 5.2.3.2.2. Non-ablative Laser Fractional Resurfacing
        • 5.2.3.2.3. Ablative Laser Resurfacing
        • 5.2.3.2.4. Infrared Devices/Radiations
        • 5.2.3.2.5. Dermabrasion
        • 5.2.3.2.6. Chemical Peels
    • 5.2.4. Market Attractiveness Analysis: Treatment
  • 5.3. Global Stretch Marks Treatment Market Outlook: Stretch Mark Type
    • 5.3.1. Introduction/Key Findings
    • 5.3.2. Historical Market Size (US$ Mn) Analysis by Stretch Mark Type, 2019-2024
    • 5.3.3. Current Market Size (US$ Mn) Forecast, by Stretch Mark Type, 2025-2032
      • 5.3.3.1. Striae atrophicans (Thinned Skin)
      • 5.3.3.2. Striae gravidarum (Post Pregnancy)
      • 5.3.3.3. Striae distensae (Stretched Skin)
      • 5.3.3.4. striae rubrae (Red)
      • 5.3.3.5. Striae albae (White)
      • 5.3.3.6. Striae nigra (Black)
      • 5.3.3.7. Striae caerulea (Dark Blue)
    • 5.3.4. Market Attractiveness Analysis: Stretch Mark Type
  • 5.4. Global Stretch Marks Treatment Market Outlook: End User
    • 5.4.1. Introduction/Key Findings
    • 5.4.2. Historical Market Size (US$ Mn) Analysis by End User, 2019-2024
    • 5.4.3. Current Market Size (US$ Mn) Forecast, by End User, 2025-2032
      • 5.4.3.1. Hospitals
      • 5.4.3.2. Dermatology Clinics
      • 5.4.3.3. Aesthetic Clinics
      • 5.4.3.4. Wellness and Spa Centers
      • 5.4.3.5. Home Care Settings
    • 5.4.4. Market Attractiveness Analysis: End User

6. Global Stretch Marks Treatment Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Mn) Analysis by Region, 2019-2024
  • 6.3. Current Market Size (US$ Mn) Forecast, by Region, 2025-2032
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia & Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Stretch Marks Treatment Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. North America Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. North America Market Size (US$ Mn) Forecast, by Treatment, 2025-2032
    • 7.4.1. Topical Medications
      • 7.4.1.1. Gels
      • 7.4.1.2. Creams
      • 7.4.1.3. Oils/Serums
    • 7.4.2. Procedural Treatments
      • 7.4.2.1. Radiofrequency Therapy
      • 7.4.2.2. Non-ablative Laser Fractional Resurfacing
      • 7.4.2.3. Ablative Laser Resurfacing
      • 7.4.2.4. Infrared Devices/Radiations
      • 7.4.2.5. Dermabrasion
      • 7.4.2.6. Chemical Peels
  • 7.5. North America Market Size (US$ Mn) Forecast, by Stretch Mark Type, 2025-2032
    • 7.5.1. Striae atrophicans (Thinned Skin)
    • 7.5.2. Striae gravidarum (Post Pregnancy)
    • 7.5.3. Striae distensae (Stretched Skin)
    • 7.5.4. striae rubrae (Red)
    • 7.5.5. Striae albae (White)
    • 7.5.6. Striae nigra (Black)
    • 7.5.7. Striae caerulea (Dark Blue)
  • 7.6. North America Market Size (US$ Mn) Forecast, by End User, 2025-2032
    • 7.6.1. Hospitals
    • 7.6.2. Dermatology Clinics
    • 7.6.3. Aesthetic Clinics
    • 7.6.4. Wellness and Spa Centers
    • 7.6.5. Home Care Settings

8. Europe Stretch Marks Treatment Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Europe Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 8.3.1. Germany
    • 8.3.2. Italy
    • 8.3.3. France
    • 8.3.4. U.K.
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Rest of Europe
  • 8.4. Europe Market Size (US$ Mn) Forecast, by Treatment, 2025-2032
    • 8.4.1. Topical Medications
      • 8.4.1.1. Gels
      • 8.4.1.2. Creams
      • 8.4.1.3. Oils/Serums
    • 8.4.2. Procedural Treatments
      • 8.4.2.1. Radiofrequency Therapy
      • 8.4.2.2. Non-ablative Laser Fractional Resurfacing
      • 8.4.2.3. Ablative Laser Resurfacing
      • 8.4.2.4. Infrared Devices/Radiations
      • 8.4.2.5. Dermabrasion
      • 8.4.2.6. Chemical Peels
  • 8.5. Europe Market Size (US$ Mn) Forecast, by Stretch Mark Type, 2025-2032
    • 8.5.1. Striae atrophicans (Thinned Skin)
    • 8.5.2. Striae gravidarum (Post Pregnancy)
    • 8.5.3. Striae distensae (Stretched Skin)
    • 8.5.4. striae rubrae (Red)
    • 8.5.5. Striae albae (White)
    • 8.5.6. Striae nigra (Black)
    • 8.5.7. Striae caerulea (Dark Blue)
  • 8.6. Europe Market Size (US$ Mn) Forecast, by End User, 2025-2032
    • 8.6.1. Hospitals
    • 8.6.2. Dermatology Clinics
    • 8.6.3. Aesthetic Clinics
    • 8.6.4. Wellness and Spa Centers
    • 8.6.5. Home Care Settings

9. East Asia Stretch Marks Treatment Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. East Asia Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. East Asia Market Size (US$ Mn) Forecast, by Treatment, 2025-2032
    • 9.4.1. Topical Medications
      • 9.4.1.1. Gels
      • 9.4.1.2. Creams
      • 9.4.1.3. Oils/Serums
    • 9.4.2. Procedural Treatments
      • 9.4.2.1. Radiofrequency Therapy
      • 9.4.2.2. Non-ablative Laser Fractional Resurfacing
      • 9.4.2.3. Ablative Laser Resurfacing
      • 9.4.2.4. Infrared Devices/Radiations
      • 9.4.2.5. Dermabrasion
      • 9.4.2.6. Chemical Peels
  • 9.5. East Asia Market Size (US$ Mn) Forecast, by Stretch Mark Type, 2025-2032
    • 9.5.1. Striae atrophicans (Thinned Skin)
    • 9.5.2. Striae gravidarum (Post Pregnancy)
    • 9.5.3. Striae distensae (Stretched Skin)
    • 9.5.4. striae rubrae (Red)
    • 9.5.5. Striae albae (White)
    • 9.5.6. Striae nigra (Black)
    • 9.5.7. Striae caerulea (Dark Blue)
  • 9.6. East Asia Market Size (US$ Mn) Forecast, by End User, 2025-2032
    • 9.6.1. Hospitals
    • 9.6.2. Dermatology Clinics
    • 9.6.3. Aesthetic Clinics
    • 9.6.4. Wellness and Spa Centers
    • 9.6.5. Home Care Settings

10. South Asia & Oceania Stretch Marks Treatment Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. South Asia & Oceania Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of SAO
  • 10.4. South Asia & Oceania Market Size (US$ Mn) Forecast, by Treatment, 2025-2032
    • 10.4.1. Topical Medications
      • 10.4.1.1. Gels
      • 10.4.1.2. Creams
      • 10.4.1.3. Oils/Serums
    • 10.4.2. Procedural Treatments
      • 10.4.2.1. Radiofrequency Therapy
      • 10.4.2.2. Non-ablative Laser Fractional Resurfacing
      • 10.4.2.3. Ablative Laser Resurfacing
      • 10.4.2.4. Infrared Devices/Radiations
      • 10.4.2.5. Dermabrasion
      • 10.4.2.6. Chemical Peels
  • 10.5. South Asia & Oceania Market Size (US$ Mn) Forecast, by Stretch Mark Type, 2025-2032
    • 10.5.1. Striae atrophicans (Thinned Skin)
    • 10.5.2. Striae gravidarum (Post Pregnancy)
    • 10.5.3. Striae distensae (Stretched Skin)
    • 10.5.4. striae rubrae (Red)
    • 10.5.5. Striae albae (White)
    • 10.5.6. Striae nigra (Black)
    • 10.5.7. Striae caerulea (Dark Blue)
  • 10.6. South Asia & Oceania Market Size (US$ Mn) Forecast, by End User, 2025-2032
    • 10.6.1. Hospitals
    • 10.6.2. Dermatology Clinics
    • 10.6.3. Aesthetic Clinics
    • 10.6.4. Wellness and Spa Centers
    • 10.6.5. Home Care Settings

11. Latin America Stretch Marks Treatment Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 11.1. Key Highlights
  • 11.2. Pricing Analysis
  • 11.3. Latin America Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of LATAM
  • 11.4. Latin America Market Size (US$ Mn) Forecast, by Treatment, 2025-2032
    • 11.4.1. Topical Medications
      • 11.4.1.1. Gels
      • 11.4.1.2. Creams
      • 11.4.1.3. Oils/Serums
    • 11.4.2. Procedural Treatments
      • 11.4.2.1. Radiofrequency Therapy
      • 11.4.2.2. Non-ablative Laser Fractional Resurfacing
      • 11.4.2.3. Ablative Laser Resurfacing
      • 11.4.2.4. Infrared Devices/Radiations
      • 11.4.2.5. Dermabrasion
      • 11.4.2.6. Chemical Peels
  • 11.5. Latin America Market Size (US$ Mn) Forecast, by Stretch Mark Type, 2025-2032
    • 11.5.1. Striae atrophicans (Thinned Skin)
    • 11.5.2. Striae gravidarum (Post Pregnancy)
    • 11.5.3. Striae distensae (Stretched Skin)
    • 11.5.4. striae rubrae (Red)
    • 11.5.5. Striae albae (White)
    • 11.5.6. Striae nigra (Black)
    • 11.5.7. Striae caerulea (Dark Blue)
  • 11.6. Latin America Market Size (US$ Mn) Forecast, by End User, 2025-2032
    • 11.6.1. Hospitals
    • 11.6.2. Dermatology Clinics
    • 11.6.3. Aesthetic Clinics
    • 11.6.4. Wellness and Spa Centers
    • 11.6.5. Home Care Settings

12. Middle East & Africa Stretch Marks Treatment Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 12.1. Key Highlights
  • 12.2. Pricing Analysis
  • 12.3. Middle East & Africa Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 12.3.1. GCC Countries
    • 12.3.2. South Africa
    • 12.3.3. Northern Africa
    • 12.3.4. Rest of MEA
  • 12.4. Middle East & Africa Market Size (US$ Mn) Forecast, by Treatment, 2025-2032
    • 12.4.1. Topical Medications
      • 12.4.1.1. Gels
      • 12.4.1.2. Creams
      • 12.4.1.3. Oils/Serums
    • 12.4.2. Procedural Treatments
      • 12.4.2.1. Radiofrequency Therapy
      • 12.4.2.2. Non-ablative Laser Fractional Resurfacing
      • 12.4.2.3. Ablative Laser Resurfacing
      • 12.4.2.4. Infrared Devices/Radiations
      • 12.4.2.5. Dermabrasion
      • 12.4.2.6. Chemical Peels
  • 12.5. Middle East & Africa Market Size (US$ Mn) Forecast, by Stretch Mark Type, 2025-2032
    • 12.5.1. Striae atrophicans (Thinned Skin)
    • 12.5.2. Striae gravidarum (Post Pregnancy)
    • 12.5.3. Striae distensae (Stretched Skin)
    • 12.5.4. striae rubrae (Red)
    • 12.5.5. Striae albae (White)
    • 12.5.6. Striae nigra (Black)
    • 12.5.7. Striae caerulea (Dark Blue)
  • 12.6. Middle East & Africa Market Size (US$ Mn) Forecast, by End User, 2025-2032
    • 12.6.1. Hospitals
    • 12.6.2. Dermatology Clinics
    • 12.6.3. Aesthetic Clinics
    • 12.6.4. Wellness and Spa Centers
    • 12.6.5. Home Care Settings

13. Competition Landscape

  • 13.1. Market Share Analysis, 2025
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles
    • 13.3.1. Weleda
      • 13.3.1.1. Company Overview
      • 13.3.1.2. Product Portfolio/Offerings
      • 13.3.1.3. Key Financials
      • 13.3.1.4. SWOT Analysis
      • 13.3.1.5. Company Strategy and Key Developments
    • 13.3.2. Clarins
    • 13.3.3. basq NYC
    • 13.3.4. Body Merry
    • 13.3.5. Himalaya Global Holdings Ltd.
    • 13.3.6. Stratpharma AG (Stratpharma Inc.)
    • 13.3.7. Browne Drug Co., Inc. (Palmer's)
    • 13.3.8. Mederma (HRA Pharma)
    • 13.3.9. Givaudan SA
    • 13.3.10. NEOSTRATA COMPANY, INC. (Johnson & Johnson Services, Inc.)
    • 13.3.11. Bio-Oil (Union Swiss (Pty) Ltd)
    • 13.3.12. Merz Pharma
    • 13.3.13. Dermaclara
    • 13.3.14. Unilever

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations